Do MCI patients with vitamin B12 deficiency have distinctive cognitive deficits?

Dina Silva1, Ulrike Albers, Isabel Santana

  • 1Dementia Clinics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. dinasilva@fm.ul.pt.

BMC Research Notes
|September 10, 2013
PubMed
Abstract

Insights

Vitamin B12 deficiency in Mild Cognitive Impairment (MCI) patients did not present a unique cognitive profile. However, deficiency may hasten symptom onset, with supplementation showing no immediate clinical benefit in this study.

Area of Science:

  • Neurology
  • Nutritional Neuroscience

Background:

  • Vitamin B12 deficiency is prevalent in older adults and linked to reversible dementia.
  • Low vitamin B12 levels are observed in patients diagnosed with Mild Cognitive Impairment (MCI).
  • The specific cognitive profile associated with vitamin B12 deficiency in MCI remains unclear.

Purpose of the Study:

  • To investigate if vitamin B12 deficiency in MCI patients is associated with a distinct cognitive impairment profile.
  • To compare cognitive symptoms and test results between MCI patients with and without vitamin B12 deficiency.

Main Methods:

  • A case-control study comparing 15 MCI patients with vitamin B12 deficiency to 45 MCI patients with normal vitamin B12 levels.
  • Analysis of subjective cognitive symptom duration and performance on neuropsychological tests.
  • Clinical observation following vitamin B12 supplementation in deficient MCI patients.

Main Results:

  • MCI patients with vitamin B12 deficiency reported significantly shorter durations of subjective cognitive symptoms (1.2 years) compared to those without deficiency (3.4 years).
  • No statistically significant differences were found in neuropsychological test performance between the two groups.
  • Vitamin B12 supplementation in deficient MCI patients did not yield noticeable clinical improvement.

Conclusions:

  • MCI patients with vitamin B12 deficiency do not exhibit a unique cognitive impairment profile.
  • Vitamin B12 deficiency may act as a precipitating factor for cognitive symptoms in MCI.
  • Further prospective studies are needed to clarify the impact of vitamin B12 supplementation in MCI patients with deficiency.

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...